Next Science Limited
NXSCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $10,491 | $11,577 | $11,234 | $12,591 |
| % Growth | -9.4% | 3.1% | -10.8% | – |
| Cost of Goods Sold | $1,766 | $2,100 | $2,272 | $3,383 |
| Gross Profit | $8,725 | $9,477 | $8,962 | $9,208 |
| % Margin | 83.2% | 81.9% | 79.8% | 73.1% |
| R&D Expenses | $3,134 | $3,241 | $3,336 | $3,258 |
| G&A Expenses | $3,654 | $3,546 | $3,205 | $2,976 |
| SG&A Expenses | $10,266 | $10,912 | $11,903 | $14,043 |
| Sales & Mktg Exp. | $6,612 | $7,366 | $8,698 | $11,050 |
| Other Operating Expenses | -$350 | -$235 | -$416 | $0 |
| Operating Expenses | $13,050 | $13,919 | $14,823 | $17,302 |
| Operating Income | -$4,325 | -$4,441 | -$5,861 | -$8,094 |
| % Margin | -41.2% | -38.4% | -52.2% | -64.3% |
| Other Income/Exp. Net | -$363 | -$302 | $18 | $104 |
| Pre-Tax Income | -$4,688 | -$4,743 | -$5,843 | -$7,990 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,688 | -$4,743 | -$5,840 | -$7,990 |
| % Margin | -44.7% | -41% | -52% | -63.5% |
| EPS | -0.016 | -0.016 | -0.03 | -0.031 |
| % Growth | 1.8% | 45.7% | 2.3% | – |
| EPS Diluted | -0.016 | -0.016 | -0.03 | -0.031 |
| Weighted Avg Shares Out | 292,177 | 290,976 | 291,704 | 260,420 |
| Weighted Avg Shares Out Dil | 292,160 | 292,098 | 291,695 | 260,420 |
| Supplemental Information | – | – | – | – |
| Interest Income | $155 | $44 | $63 | $448 |
| Interest Expense | $531 | $253 | $31 | $399 |
| Depreciation & Amortization | $231 | $234 | $600 | $607 |
| EBITDA | -$4,094 | -$4,123 | -$5,261 | -$6,984 |
| % Margin | -39% | -35.6% | -46.8% | -55.5% |